Paul Kwo, M.D. from Indiana University, will be joining Dr. Galati to discuss advances in chronic hepatitis C. This past week, and article in the British medical journal, Lancet, published and article on new advances in the therapy of hepatitis C. Dr. Kwo was the lead aurthor in this publication. Dr. Galati was a contributing author and researcher in the study, along with Dr. Kwo.
Hepatitis C is an infection caused by a virus that attacks the liver and leads to inflammation. Most people infected with the hepatitis C virus (HCV) have no symptoms. In fact, most people don't know they have the hepatitis C infection until liver damage shows up, decades later, during routine medical tests.
Hepatitis C is one of several hepatitis viruses and is generally considered to be among the most serious of these viruses. Hepatitis C is passed through contact with contaminated blood — most commonly through needles shared during illegal drug use.
There are over 4 million american with hepatitis C. If you have any risk factors for hepatitis C, you need to get screened regardless of how you feel or your lab test results.
More information on hepatitis C can be obtained from the links below.
How can i get more Information about this therapy? I'm from Germany and i was looking for Information...please give me some information.Can somebody help me?
Personal Spotlight:
James T. McCullough
learn more
LifeGift Organ Donation Center is dedicated to recovering organs and tissue for individuals needing transplants. LifeGift serves
men, women and children in 109 counties in Southeast, North and West Texas.
•
del.icio.us
digg
facebook
How can i get more Information about this therapy? I'm from Germany and i was looking for Information...please give me some information.Can somebody help me?